Fig. 1: Distribution of startup deals among European countries. | Nature Biotechnology

Fig. 1: Distribution of startup deals among European countries.

From: Mapping the European startup landscape

Fig. 1

a, The number of biomedical startup deals in Europe (2013–2017) is indicated by color shading and shown in absolute numbers on the map. b, The bars represent the number of startup deals (2013–2017) scaled per capita. The dotted line represents the median. Countries are referred to by their two-letter ISO-2 codes: AT, Austria; BE, Belgium; CH, Switzerland; DE, Germany; DK, Denmark; ES, Spain; FI, Finland; FR, France; GB, the UK; IE, Ireland; IT, Italy; NL, the Netherlands; NO, Norway; PL, Poland; PT, Portugal; SE, Sweden.

Back to article page